Castration-resistant prostate cancer registry: An observational study in the Netherlands.
Phase of Trial: Phase IV
Latest Information Update: 23 Oct 2018
At a glance
- Drugs Abiraterone (Primary) ; Antineoplastics (Primary) ; Cabazitaxel (Primary) ; Enzalutamide (Primary) ; Radium 223 chloride (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms CAPRI
- 01 Aug 2013 Additional lead trial centres identified as reported by Netherlands Trial Register.
- 01 Aug 2013 Status changed from planning to recruiting as reported by Netherlands Trial Register.
- 22 Sep 2012 Status changed from not yet recruiting to planning as reported by Netherlands Trial Register record.